BIOTRONIK Announces First-Ever Clinical Implantation of LivIQ, the World’s First Leadless Pacemaker with Far-Field Atrial Sensing

Biotronik(BIOTRONIK) announced that itsLeadless Pacemaker---LivIQCompletion of the first batch of clinical enrollments. This isBIO|CONCEPT.LivIQ ClinicalResearchStudyPart of this is a pre-market clinical study designed to evaluate the initial safety and performance of the system.

PI Evaluation

"The ease of use of the delivery system impressed me. It enables precise and stable positioning, and allows for easy adjustments when necessary."

---Paul Gould Princess Alexandra Hospital 

"In terms of imaging, Biotronik has considered everything very comprehensively. The imaging effects of the fixed-wing and pull-back structures are excellent, and the delivery system is intuitively designed and easy to operate."

---Stewart HealyAndEmily Kotschet  Victorian Heart Hospital 

Executive Evaluation

"We plan to launch a global pivotal study in the coming months. Introducing DX technology into wireless pacing is a significant advancement in the treatment of bradycardia, and we look forward to bringing this innovation to patients worldwide as soon as possible."

---Andreas Hecker Chief Technology Officer of Biotronik

LivIQThis leadless pacemaker is the world's first to adoptAtrial Far-field Sensing TechnologyThe intracardiac pacemaker can achieve functionality at rest and during exercise with only a single cardiovascular implantable electronic device.Atrioventricular Synchronous PacingIts design simplifies the implantation process through intuitive operation and optimized intraoperative visibility, ensuring reliable frequency adaptation without compromising device lifespan.

Since Abbott (St. Jude) launched the first leadless pacemaker, Nanostim LPM, in 2012, 14 years have passed. Today, leadless pacemakers have significantly reduced complications associated with traditional pacemakers (such as lead dislodgement,Infections, etc.), increasingly becoming patients with bradycardiaTreatment of choice. The market is currently dominated by Medtronic and Abbott, while Boston Scientific, Biotronik, and others are breaking the monopoly held by Medtronic and Abbott. These new players will provide a wide range of options forProvide more options for patients with bradycardia.

Biotronik stated that LivIQ, while retaining the advantages of traditional leadless pacemakers, also integrates advanced features, setting a new benchmark for wireless pacing technology.

Bai DuoForce (BIOTRONIK) isA global leading medical technology company whose products and services can save and improve the lives of millions of people suffering from heart and vascular diseases as well as chronic pain. We are committed to perfectly matching technology with the human body and dedicated to developing value.TrustedCardiac Rhythm Management, Monitoring, and Neuromodulation FieldsSolution.